ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
127.122,25
0,95%
S&P 500
5.064,20
0,91%
US Dollar vs BRL
5,1112
-0,01%
Bitcoin
59.034,15
-0,15%
Brent Oil
83,855
0,27%
Registration Strip Icon for default Cadastre-se gratuitamente para obter cotações em tempo real, gráficos interativos, fluxo de opções ao vivo e muito mais.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Vaxart Inc (VXRT)

  7. Vaxart Inc (VXRT) Notícias

VXRT

Vaxart (VXRT)

Vaxart Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:VXRT
DataHoraFonteTítuloCódigoCompanhia
30/04/202409:00GlobeNewswire Inc.Vaxart Announces Positive Results for Its Bivalent Norovirus Vaccine Candidate in Lactating MothersNASDAQ:VXRTVaxart Inc
27/03/202409:00GlobeNewswire Inc.Vaxart to Present at World Vaccine Congress Washington 2024 on April 3NASDAQ:VXRTVaxart Inc
20/03/202409:00GlobeNewswire Inc.Vaxart, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:VXRTVaxart Inc
14/03/202417:01GlobeNewswire Inc.Vaxart Provides Business Update and Reports Full Year 2023 Financial ResultsNASDAQ:VXRTVaxart Inc
14/03/202408:41IH Market NewsU.S. Stock Futures Rise Ahead Of PPI and Retail Sales; Oil Prices ClimbNASDAQ:VXRTVaxart Inc
07/03/202410:00GlobeNewswire Inc.Vaxart to Host Full Year 2023 Business Update and Financial Results Conference Call on March 14NASDAQ:VXRTVaxart Inc
06/03/202411:23Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VXRTVaxart Inc
06/03/202410:00GlobeNewswire Inc.Vaxart, Inc. Appoints Steven Lo as President, Chief Executive Officer, and DirectorNASDAQ:VXRTVaxart Inc
13/02/202419:16Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:VXRTVaxart Inc
05/02/202410:00GlobeNewswire Inc.Vaxart Announces Publication in Vaccines of Non-Human Primate Preclinical Data Demonstrating Its Next-Generation Vaccine Candidates Elicit Mucosal and Systemic Immunogenicity and Reduce Viral Shedding after SARS-CoV-2 ChallengeNASDAQ:VXRTVaxart Inc
02/02/202418:49Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:VXRTVaxart Inc
19/01/202418:30Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:VXRTVaxart Inc
19/01/202410:30GlobeNewswire Inc.Vaxart Receives $9.27 Million BARDA Project NextGen Award to Prepare for Phase 2b Clinical Study Evaluating Its COVID-19 Oral Pill Vaccine CandidateNASDAQ:VXRTVaxart Inc
16/01/202411:25GlobeNewswire Inc.Vaxart Announces $10.0 Million Registered Direct Offering with RA Capital ManagementNASDAQ:VXRTVaxart Inc
16/01/202411:22GlobeNewswire Inc.Vaxart, Inc. Announces Management ChangeNASDAQ:VXRTVaxart Inc
21/12/202310:00GlobeNewswire Inc.Vaxart Announces Last Subject Dosed in Phase 1 Trial of Its Norovirus Vaccine Candidate in Lactating MothersNASDAQ:VXRTVaxart Inc
02/11/202317:16Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:VXRTVaxart Inc
02/11/202317:01GlobeNewswire Inc.Vaxart Provides Business Update and Reports Third Quarter 2023 Financial ResultsNASDAQ:VXRTVaxart Inc
02/11/202309:00GlobeNewswire Inc.Vaxart Doses First Subject in Phase 1 Trial of Its Norovirus Vaccine Candidate in Lactating MothersNASDAQ:VXRTVaxart Inc
26/10/202309:00GlobeNewswire Inc.Vaxart to Host Third Quarter 2023 Business Update and Financial Results Conference Call on November 2NASDAQ:VXRTVaxart Inc
11/10/202309:00GlobeNewswire Inc.Vaxart to Present at World Vaccine Congress Europe 2023 on October 18-19NASDAQ:VXRTVaxart Inc
21/09/202309:00GlobeNewswire Inc.Vaxart to Participate in Fireside Chat at 2023 Cantor Global Healthcare ConferenceNASDAQ:VXRTVaxart Inc
06/09/202317:05GlobeNewswire Inc.Vaxart Announces Topline Data from the Phase 2 Challenge Study of its Monovalent Norovirus Vaccine CandidateNASDAQ:VXRTVaxart Inc
03/08/202317:01GlobeNewswire Inc.Vaxart Provides Business Update and Reports Second Quarter 2023 Financial ResultsNASDAQ:VXRTVaxart Inc
01/08/202322:23Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VXRTVaxart Inc
27/07/202309:00GlobeNewswire Inc.Vaxart to Host Second Quarter 2023 Business Update and Financial Results Conference Call on August 3NASDAQ:VXRTVaxart Inc
06/07/202309:00GlobeNewswire Inc.Vaxart Announces Positive Preliminary Topline Data from Dose-Ranging Phase 2 Study of its Bivalent Norovirus Vaccine CandidateNASDAQ:VXRTVaxart Inc
28/06/202317:23Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:VXRTVaxart Inc
26/06/202317:45GlobeNewswire Inc.Vaxart Stockholders Approve All Four Proposals in the 2023 Proxy StatementNASDAQ:VXRTVaxart Inc
21/06/202318:19Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:VXRTVaxart Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:VXRT

Seu Histórico Recente

BOV
IBOV
Índice Bovespa
BOV
PRIO3
PETRORIO ON
BOV
TELB4
TELEBRAS PN
BOV
BBDC4
BRADESCO PN
BOV
COGN3
COGNA ON
BOV
BHIA3
Grupo Casas Bahia ON
BOV
GOLL4
GOL PN
BOV
BEES3
BANESTES ON
Delayed Upgrade Clock
ADVFN Logo

Brasil
Empresa
Negócios
Popular
Obter o aplicativo

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados